Tarsus Bets Up To $800M On Alkeus In Retina Therapy Push
By Al Barbarino · August 6, 2026, 4:43 PM EDT
Tarsus Pharmaceuticals Inc. said Thursday it has agreed to acquire privately held Alkeus Pharmaceuticals Inc. for up to approximately $800 million, expanding the Irvine, California-based eye care company's pipeline into retinal...
To view the full article, register now.